Amgen, Inc. (NASDAQ: AMGN) reported Q3 EPS of $1.67, $0.20 better than the analyst estimate of $1.47. Revenue for the quarter came in at $4.32 billion versus the consensus estimate of $4.25 billion.

Amgen, Inc. sees FY2012 EPS of $6.50-6.60, versus the consensus of $6.35. Amgen, Inc. sees FY2012 revenue of $17.2-17.3 million, versus the consensus of $17.04 million.

For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.

Earnings Guidance Hot Earnings Hot Guidance